Bowie Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Buy
+48,517
New +$23.3M 1.04% 27
2024
Q3
– Sell
-43,400
Closed -$24M – 36
2024
Q2
$24M Sell
43,400
-39,558
-48% -$22.7M 1.47% 24
2024
Q1
$48.2M Buy
82,958
+4,642
+6% +$2.6M 3.61% 16
2023
Q4
$41.6M Buy
78,316
+14,613
+23% +$7.07M 4.7% 10
2023
Q3
$32.2M Buy
63,703
+19,373
+44% +$10.3M 2.75% 14
2023
Q2
$23.1M Buy
+44,330
New +$23.9M 2.71% 20

Other funds holding TMO

Bowie Capital Management's TMO Position: Q2 2026 in Review

Bowie Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 48,517 shares worth $24.3M. The stake represents 1.04% of the portfolio and ranks #27 among its holdings. This is a return to the name: Bowie Capital Management previously reported a position in TMO as recently as Q2 2024.

Bowie Capital Management first reported a position in TMO in Q2 2023 and has held it in 6 quarters since. The position peaked at $48.2M in Q1 2024. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bowie Capital Management held 48,517 shares of Thermo Fisher Scientific worth $24.3M as of Q2 2026.
  • Thermo Fisher Scientific was a new Bowie Capital Management position in Q2 2026.
  • Thermo Fisher Scientific made up 1.04% of Bowie Capital Management's portfolio in Q2 2026, its #27 holding.
  • Bowie Capital Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 6 quarters since.
  • Bowie Capital Management's Thermo Fisher Scientific position peaked at $48.2M in Q1 2024.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bowie Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.